The efficacy and safety of chemo‐free therapy in epidermal growth factor receptor tyrosine kinase inhibitor‐resistant advanced non‐small cell lung cancer: A single‐arm, phase II study

OBJECTIVES: The purpose of this study was to explore the efficacy and safety of toripalimab combined with anlotinib in patients with advanced non‐small cell lung cancer (NSCLC) who acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs). MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuyang, Yang, Lu, Yang, Yaning, Yang, Guangjian, Xu, Haiyan, Niu, Xueliang, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587943/
https://www.ncbi.nlm.nih.gov/pubmed/37723846
http://dx.doi.org/10.1002/cam4.6545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587943/
https://www.ncbi.nlm.nih.gov/pubmed/37723846
http://dx.doi.org/10.1002/cam4.6545

Ejemplares similares